You are here: Home » Reuters » News
Business Standard

Shire to sell oncology business to Servier for $2.4 billion

Reuters  |  LONDON 

LONDON (Reuters) - Shire, the London-listed pharmaceutical company which specialises in rare diseases, said on Monday it was selling its oncology business to French drug maker Servier for $2.4 billion.Shire, which is a possible bid target for Japan's largest drugmaker Takeda Pharmaceutical, said it would consider returning the proceeds of the sale to shareholders through a buyback. (Reporting by Sarah Young; editing by Kate Holton)(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Mon, April 16 2018. 12:28 IST